Related Experiment Video
Updated: Apr 16, 2026
Quantification of Colonic Stem Cell Mutations
Published on: September 25, 2015
[Molecular identification of glucose-6-phosphate dehydrogenase (G6PD) detected in neonatal screening]
Clara Aurora Zamorano-Jiménez1, Héctor Alfredo Baptista-González2, Patricia Bouchán-Valencia2,3
1Universidad Nacional Autónoma de México, Maestria en Ciencias Medicas, UNAM, México, D.F.
Aims:
To present the strategy of identifying the molecular variants of G6PD detected in neonatal screening (NS).
Material And Methods:
We present a series of incident cases of newborns positive for G6PD deficiency detected in NS. From nuclear DNA with the methodology of real-time PCR we sought molecular G6PD variants: G202A, A376G, T968C and C563T.
Results:
Of a total of 21,619 neonates, 41 cases were reactive in NS for G6PD (189.6/100,000 RN screened rate), 34 cases confirmed the molecular variant of G6PD (157.3/100,000 RN screened rate). The most frequent allele combination G202A/A376G (G6PD ratio and median activity, 0.460 and 1.72 ± 0.35 U/g Hb, respectively), followed by G202A (0.170 and 1.74 ± 0.27 U/g Hb) and A376G/T968C (ratio 0.150 and 1.10 ± 0.44 U/g Hb). The T968C allelic variant showed lower enzyme activity than the rest (1.1 ± 0.4; p = 0.02). Two women were detected with G6PD deficiency with G202A/A376G and G202A variant.
Conclusions:
African alleles were prevalently detected in neonatal screening. This strategy allows the identification of molecular variants involved in 80% of cases.
